Innovative Diagnostic Technology Neuronetrix's COGNISION™ system offers a noninvasive, advanced neurodiagnostic solution that can be integrated into clinical and research settings focused on cognitive disorders, presenting a promising opportunity to expand sales within hospitals, clinics, and academic institutions.

Expanding Clinical Applications The system's demonstrated use in assessments for disorders such as Alzheimer's, ADHD, and traumatic brain injuries indicates a broad potential market, especially with healthcare providers seeking reliable tools for early diagnosis and monitoring of neurological conditions.

Potential for Government and Military Contracts The successful deployment of COGNISION™ by the US Army for evaluating blast injuries suggests opportunities to collaborate with government agencies and military health programs seeking innovative cognitive assessment tools.

Growth in Neuroscience Markets With competitors ranging from startups to established firms like Blackrock Neurotech, there is significant market interest in neurodiagnostic solutions, making Neuronetrix well-positioned to target this expanding sector with tailored sales strategies.

Upside in Investment and Funding Although current revenue is modest, the company's innovative technology and market niche indicate strong growth potential, enhancing prospects for future funding, partnerships, and sales expansion within specialized healthcare segments.